Suvretta Capital Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Suvretta Capital Management, LLC

$2.28 Billion
Q1 2025

A detailed history of Suvretta Capital Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 2,024,500 shares of RARE stock, worth $83.9 Million. This represents 3.21% of its overall portfolio holdings.

Number of Shares

2,024,500

Previous 1,151,314 75.84%

Holding current value

$83.9 Million

Previous $48.4 Million 51.35%

% of portfolio

3.21%

Previous 2.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$36.21 - $45.78 $31.6 Million - $40 Million	873,186 Added 75.84%	2,024,500 $73.3 Million
Q3 2024 Nov 14, 2024	SELL	$40.21 - $59.36 $36.6 Million - $54 Million	-910,112 Reduced 44.15%	1,151,314 $64 Million
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $14.4 Million - $19.8 Million	384,615 Added 22.94%	2,061,426 $84.7 Million
Q1 2024 May 15, 2024	SELL	$43.02 - $53.69 $19.3 Million - $24.1 Million	-449,495 Reduced 21.14%	1,676,811 $78.3 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $45.9 Million - $71.2 Million	1,446,847 Added 212.94%	2,126,306 $102 Million
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $4.82 Million - $6.44 Million	137,979 Added 25.48%	679,459 $24.2 Million
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $2.8 Million - $3.91 Million	-75,000 Reduced 12.17%	541,480 $25 Million
Q1 2023 May 15, 2023	SELL	$36.99 - $48.71 $7.42 Million - $9.78 Million	-200,691 Reduced 24.56%	616,480 $24.7 Million
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $24.6 Million - $33.7 Million	728,231 Added 818.79%	817,171 $37.9 Million
Q3 2022 Nov 14, 2022	SELL	$39.96 - $66.14 $10.4 Million - $17.2 Million	-259,579 Reduced 74.48%	88,940 $3.68 Million
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $8.09 Million - $15.1 Million	-176,581 Reduced 33.63%	348,519 $20.8 Million
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $2.48 Million - $3.36 Million	39,858 Added 8.21%	525,100 $38.1 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $35.8 Million - $42.6 Million	485,242 New	485,242 $40.8 Million

Others Institutions Holding RARE

# of Institutions

337

Shares Held

89.8M

Call Options Held

1.08M

Put Options Held

1.04M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.9B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Account

Suvretta Capital Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History